Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

Lung Cancer: Genetics Of Risk And Advances In Chemoprevention

R. Keith, Y. Miller
Published 2005 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Purpose of review The current article reviews recent advances in genetic susceptibility and chemoprevention of lung cancer. Recent findings Linkage analysis has identified a locus on chromosome 6q23-25 that determines susceptibility to lung cancer in families with multiple members with cancer of the lung, throat, and larynx. Obligate gene carriers are sensitive to even small tobacco smoke exposure in terms of increased lung cancer risk. Variation in other genes, particularly those regulating the activation or inactivation of carcinogens, has been implicated in determining lung cancer risk. Epidemiologic and preclinical studies suggest that chemoprevention of lung cancer is an achievable goal. Early trials with β-carotene supplementation, however, have revealed a harmful effect. Promising new agents must be evaluated in both preclinical models and in intermediate end point biomarker trials before being taken to large primary prevention trials, and lung cancer chemoprevention should only be attempted within controlled clinical trials. Summary We are poised to learn a great deal about the genetic susceptibility to lung cancer, which will not only allow definition of groups with extremely high risk, but may also yield new insights into processes that determine innate susceptibility or resistance to lung carcinogenesis. Chemoprevention of lung cancer is not yet ready for clinical application. As a result of the large number of lung cancer deaths and the large number of at-risk individuals, even modestly effective chemoprevention could save many lives.
This paper references
10.1136/THORAX.2003.013094
BTS guidelines for the management of pleural infection.
C. Davies (2003)
10.1016/J.ATHORACSUR.2004.04.085
Pulmonary resection after curative intent radiotherapy (>59 Gy) and concurrent chemotherapy in non-small-cell lung cancer.
J. Sonett (2004)
10.1055/S-2004-821155
Results of surgical treatment for non-small cell lung cancer of 20 mm or less in diameter.
A. Iwasaki (2004)
10.1038/sj.onc.1208051
FLIP overexpression inhibits death receptor-induced apoptosis in malignant mesothelial cells
Maria Rita Rippo (2004)
Pneumothorax: management and diagnosis
10.1016/J.ATHORACSUR.2004.02.026
Combined off-pump coronary artery bypass surgery and pulmonary resection.
P. Saxena (2004)
10.1038/sj.bjc.6602062
Treatment of non-small-cell lung cancer: a perspective on the recent advances and the experience with gefitinib
A. Onn (2004)
PET for the evaluation of pleural thickening observed on CT.
H. Kramer (2004)
10.1378/CHEST.126.2.347
Improved survival in never-smokers vs current smokers with primary adenocarcinoma of the lung.
L. Nordquist (2004)
10.1148/RADIOL.2331031133
Asbestos-related pleuropulmonary diseases: evaluation with low-dose four-detector row spiral CT.
M. Remy-Jardin (2004)
10.1378/CHEST.126.3.986
Bilateral pleural effusions and right pneumothorax in a 25-year-old man.
Eric J Olafsson (2004)
10.1056/NEJMOA040938
Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib.
T. Lynch (2004)
10.1126/SCIENCE.1099314
EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
J. Paez (2004)
10.1378/CHEST.125.5.1776
Percutaneous multiple-site parietal pleural biopsy: description and evaluation of a new and safe technique.
B. Uthaman (2004)
10.1080/09629350410001688486
Involvement of steroids in anti-inflammatory effects of PK11195 in a murine model of pleurisy.
M. B. D. da Silva (2004)
10.1080/01902140490517836
LUNG DISTRIBUTION OF THE CHEMOPREVENTIVE AGENT DIFLUOROMETHYLORNITHINE (DFMO) FOLLOWING ORAL AND INHALATION DELIVERY
Xiangmin Liao (2004)
10.1378/chest.125.6.1982
SARS, Pneumothorax, and Our Response to Epidemics
G. Filice (2004)
10.1378/CHEST.126.6.2007
Idiopathic pleuroparenchymal fibroelastosis: description of a novel clinicopathologic entity.
S. Frankel (2004)
10.1016/J.IJROBP.2004.04.022
Time course of serum cytokines in patients receiving proton or combined photon/proton beam radiation for resectable but medically inoperable non-small-cell lung cancer.
D. Gridley (2004)
10.1093/CARCIN/21.2.179
Chemoprevention of pulmonary carcinogenesis by brief exposures to aerosolized budesonide or beclomethasone dipropionate and by the combination of aerosolized budesonide and dietary myo-inositol.
L. Wattenberg (2000)
10.1016/J.CLINIMAG.2004.05.001
CT screening for lung cancer Assessing a regimen's diagnostic performance.
C. Henschke (2004)
10.7326/0003-4819-141-3-200408030-00028
Successful octreotide treatment of chylous pleural effusion and lymphedema in the yellow nail syndrome.
K. Makrilakis (2004)
10.1038/sj.bjc.6601638
The Mesothelioma epidemic in Western Europe: an update
C. Pelucchi (2004)
10.1016/J.ATHORACSUR.2003.09.139
Video-assisted thoracic surgery upper lobe trisegmentectomy for early-stage left apical lung cancer.
W. Houck (2004)
Cancer. A bull's eye for targeted lung cancer therapy.
J. Minna (2004)
10.1093/CARCIN/23.10.1653
Celecoxib reduces pulmonary inflammation but not lung tumorigenesis in mice.
Lori R Kisley (2002)
10.1016/J.ATHORACSUR.2004.05.017
Bronchioloalveolar carcinoma of the lung 3 centimeters or less in diameter: a prognostic assessment.
H. Sakurai (2004)
10.1093/JNCI/DJH143
Lung cancer rates in men and women with comparable histories of smoking.
C. Bain (2004)
10.1378/CHEST.126.5.1412
Long-term results of intrapericardial chemotherapeutic treatment of malignant pericardial effusions with thiotepa.
Alessandro Martinoni (2004)
10.1378/CHEST.125.4.1190
Management of secondary spontaneous pneumothorax: there's confusion in the air.
J. Heffner (2004)
10.1038/sj.bjc.6602063
Interstitial lung disease associated with drug therapy
P. Camus (2004)
10.1378/CHEST.125.4.1328
Prognostic factors in the surgical management of pericardial effusion in the patient with concurrent malignancy.
C. Cullinane (2004)
An oncogenic KRAS 2 expression signature identified by cross - species gene - expression analysis
S Tomida
Comparison of walter seal and suction after pulmonary lobectomy : A prospective , randomized trial
A Brunelli (2004)
Manipulation of pulmonary prostacyclin synthase expression prevents murine lung cancer.
R. Keith (2002)
10.1016/J.ATHORACSUR.2003.10.089
Bronchial carcinoid tumors: nodal status and long-term survival after resection.
G. Cardillo (2004)
10.1378/CHEST.125.2.439
Impact of respiratory symptoms and pulmonary function on quality of life of long-term survivors of non-small cell lung cancer.
L. Sarna (2004)
10.1016/J.ATHORACSUR.2004.02.017
Benefits of surgery for patients with pulmonary metastases from colorectal carcinoma.
M. Inoue (2004)
10.1183/09031936.04.00007804
Penetration of newer quinolones in the empyema fluid
I. Liapakis (2004)
10.3816/CLC.2002.N.012
The future of cyclooxygenase-2 inhibitors and other inhibitors of the eicosanoid signal pathway in the prevention and therapy of lung cancer.
P. Bunn (2002)
10.1093/JNCI/94.13.1001
A randomized phase IIb trial of anethole dithiolethione in smokers with bronchial dysplasia.
S. Lam (2002)
10.1038/sj.bjc.6602134
Prognostic value of nonangiogenic and angiogenic growth patterns in non-small-cell lung cancer
P. Sardari Nia (2004)
10.1378/CHEST.126.6.2022
Diagnostically significant variations in pleural fluid pH in loculated parapneumonic effusions.
N. Maskell (2004)
10.1038/sj.bjc.6602296
CYFRA 21-1 level predicts survival in non-small-cell lung cancer patients receiving gefitinib as third-line therapy
F. Barlesi (2005)
10.1378/CHEST.125.4.1315
An Audit of medical thoracoscopy and talc poudrage for pneumothorax prevention in advanced COPD.
P. Lee (2004)
10.1378/chest.125.5.1965
Effect of repeated thoracenteses on fibrinolytic activity in malignant pleural effusion.
H. Ishikawa (2004)
10.1093/JNCI/93.18.1385
Fluorescence versus white-light bronchoscopy for detection of preneoplastic lesions: a randomized study.
F. Hirsch (2001)
10.1378/CHEST.126.1.129
Echogenic swirling pattern as a predictor of malignant pleural effusions in patients with malignancies.
C. Chian (2004)
10.1001/JAMA.290.16.2149
Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer: a randomized trial.
M. Kris (2003)
10.1378/CHEST.125.5.1604
Malignant pleural mesothelioma: the puzzling role of gene-environment interaction.
G. D. Di Maria (2004)
10.1378/CHEST.125.6.2356
Fluorodeoxyglucose positron emission tomography and CT after talc pleurodesis.
B. H. Kwek (2004)
10.2298/vsp0305613t
[Chylous effusions].
I. Tomić (2003)
10.1016/S1053-2498(03)00227-4
Chylothorax after heart/lung transplantation.
T. Ziedalski (2004)
10.1016/J.ATHORACSUR.2003.10.058
Visceral pleural involvement in nonsmall cell lung cancer: prognostic significance.
T. Osaki (2004)
10.1002/cncr.20315
Adapting the Lung Cancer Symptom Scale (LCSS) to mesothelioma
P. Hollen (2004)
10.1056/nejm200405063501921
Multidisciplinary management of lung cancer.
A. Buyukcelik (2004)
Sputum cytological atypia as a predictor of incident lung cancer in a cohort of heavy smokers with airflow obstruction.
S. Prindiville (2003)
10.1038/sj.bjc.6601987
Serum EGF-receptor and HER-2 extracellular domains and prognosis of non-small-cell lung cancer
W. Jacot (2004)
10.1002/ijc.20552
Explaining differences in incidence rates of pleural mesothelioma between Sweden and the Netherlands
A. Burdorf (2005)
10.1016/S0378-4274(99)00208-8
Chemoprevention of cancer: lessons to be learned from beta-carotene trials.
H. Vainio (2000)
10.1016/J.HRTLNG.2003.10.005
Difficulties in the diagnosis of rare immunological diseases manifesting with cystic lung disease and spontaneous pneumothorax: Case reports.
P. Krawczyk (2004)
10.1016/S0140-6736(04)15878-9
Preventive oncology—lessons from preventive cardiology
A. Neugut (2004)
10.1378/CHEST.126.5.1516
Incidence and risk factors of delayed pneumothorax after transthoracic needle biopsy of the lung.
C. Choi (2004)
10.1002/ijc.20527
Downregulation of tissue factor by RNA interference in human melanoma LOX‐L cells reduces pulmonary metastasis in nude mice
Xiaolin Wang (2004)
10.1002/PPUL.20100
Pulmonary lymphangiectasia: Diagnosis and clinical course
C. Esther (2004)
10.1016/J.IJROBP.2004.08.015
In regard to Bogart et al.: 70 Gy thoracic radiotherapy is feasible concurrent with chemotherapy for limited-stage non-small-cell lung cancer: Analysis of cancer and leukemia group B study 39808 (Int J Radiat Oncol Biol Phys 2004;59:460-468).
F. Casas (2004)
10.1016/J.ATHORACSUR.2003.12.022
Comparison of water seal and suction after pulmonary lobectomy: a prospective, randomized trial.
A. Brunelli (2004)
10.1378/CHEST.125.5_SUPPL.149S
Mechanisms of lung cancer chemoprevention by D-glucarate.
Z. Walaszek (2004)
10.1378/CHEST.125.1.156
Clinical implications of appearance of pleural fluid at thoracentesis.
V. Villena (2004)
10.1055/S-2004-821166
Late postpneumonectomy bronchopleural fistula.
K. Athanassiadi (2004)
10.1038/sj.bjc.6601775
Relationship between 3p deletions and telomerase activity in non-small-cell lung cancer: prognostic implications
P. Iniesta (2004)
10.1378/CHEST.125.5.1747
CT fluoroscopy-guided bronchoscopic dye marking for resection of small peripheral pulmonary nodules.
M. Endo (2004)
10.1159/000081755
Outpatient Management of Malignant Pleural Effusions with Small-Bore, Tunneled Pleural Catheters
A. Musani (2004)
Intrapleural injection of monoclonal antibody to TGF - b halts empyema progression and blocks fibrosis in experimental empyema
JM Porcel (2003)
10.7326/0003-4819-106-4-512
Airways obstruction and the risk for lung cancer.
M. Tockman (1987)
10.1016/J.ATHORACSUR.2004.01.024
Segmental resection spares pulmonary function in patients with stage I lung cancer.
R. Keenan (2004)
10.1159/000079648
Combined Use of Autofluorescence Bronchoscopy and Argon Plasma Coagulation Enables Less Extensive Resection of Radiographically Occult Lung Cancer
B. Schuurman (2004)
10.1016/J.AMJMED.2003.11.008
Measurement of pro-brain natriuretic peptide in pleural fluid for the diagnosis of pleural effusions due to heart failure.
J. M. Porcel (2004)
10.1016/J.ATHORACSUR.2004.05.025
Intrapleural hyperthermic perfusion with chemotherapy increases apoptosis in malignant pleuritis.
Y. Matsuzaki (2004)
10.1016/S0084-3873(08)70473-5
Lung Cancer Screening With Sputum Cytologic Examination, Chest Radiography, and Computed Tomography: An Update for the US Preventive Services Task Force
L. Tanoue (2006)
10.1016/J.ATHORACSUR.2003.10.057
Lung wedge resection improves outcome in stage I primary spontaneous pneumothorax.
M. Czerny (2004)
10.1038/nrc1432
Gene-promoter hypermethylation as a biomarker in lung cancer
S. Belinsky (2004)
10.1016/S0003-4975(03)01601-1
Salvage intensive care following initial recovery from pulmonary resection: is it justified?
John E Pilling (2004)
10.1016/J.ATHORACSUR.2003.10.082
Predictors of prolonged air leak after pulmonary lobectomy.
A. Brunelli (2004)
10.1055/S-2004-820901
Hemi-clamshell approach for advanced primary lung cancer.
M. Ohta (2004)
10.1016/S0003-4975(03)01282-7
Spontaneous biliopneumothorax (thoracobilia) following gastropleural fistula due to stomach perforation by nasogastric tube.
A. Bini (2004)
10.1542/PEDS.113.3.E182
Effectiveness and safety of tissue plasminogen activator in the management of complicated parapneumonic effusions.
M. Weinstein (2004)
Paradigm shift in surgical approaches to spontaneous pneumothorax: VATS.
C. Ng (2004)
10.1016/J.IJROBP.2004.05.055
Evaluation of internal lung motion for respiratory-gated radiotherapy using MRI: Part I--correlating internal lung motion with skin fiducial motion.
N. Koch (2004)
10.1378/CHEST.126.1.298
A new radiologic appearance of pulmonary thromboembolism: multiloculated pleural effusions.
L. Erkan (2004)
10.1016/J.ATHORACSUR.2003.10.009
Endoscopic ultrasound in lung cancer patients with a normal mediastinum on computed tomography.
M. Wallace (2004)
10.1053/CLON.2002.0119
Fatal pulmonary fibrosis associated with induction chemotherapy with carboplatin and vinorelbine followed by CHART radiotherapy for locally advanced non-small cell lung cancer.
P. Kirkbride (2002)
10.1016/J.ATHORACSUR.2004.05.058
Isolated lung perfusion with melphalan for resectable lung metastases: a phase I clinical trial.
J. Hendriks (2004)
10.1016/S0169-5002(00)00232-4
Primary lung tumors in mice as an aid for understanding, preventing, and treating human adenocarcinoma of the lung.
A. M. Malkinson (2001)
10.1016/J.LUNGCAN.2004.01.024
What is early lung cancer? A review of the literature.
A. Pasic (2004)
10.1378/CHEST.125.5.1951
Kapalabhati pranayama: breath of fire or cause of pneumothorax? A case report.
D. B. Johnson (2004)
New technique for treating spontaneous pneumothorax.
K. Roberts (2004)
10.1093/OCCMED/KQH073
Occupational respiratory disease in mining.
M. H. Ross (2004)
10.1016/J.JTCVS.2004.02.017
Thoracic surgical operations in patients enrolled in a computed tomographic screening trial.
J. Crestanello (2004)
10.1378/CHEST.126.1.135
Cytokine response to pulmonary thromboendarterectomy.
F. Langer (2004)
10.1378/CHEST.125.5.1735
Actual and predicted postoperative changes in lung function after pneumonectomy: a retrospective analysis.
S. A. Smulders (2004)
10.1016/J.ATHORACSUR.2004.05.064
Long-term survival after resection of primary adenoid cystic and squamous cell carcinoma of the trachea and carina.
H. Gaissert (2004)
Tuberculous pleural effusion - Reply
Davis RJO (2004)
Carcinoid: diagnosis and management
10.1016/S0140-6736(77)90663-8
A COMMON FAMILIAL COMPONENT IN LUNG CANCER AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE
B. Cohen (1977)
10.1080/09511920410001713475
Levels of superoxide dismutase and malondialdehyde in primary spontaneous pneumothorax.
E. Tabakoğlu (2004)
GSTM 1 , smoking and lung cancer : a case — control study
W Qingyi (1999)
Treatment and Prevention of Intraepithelial Neoplasia: An Important Target for Accelerated New Agent Development: Recommendations of the American Association for Cancer Research Task Force on the Treatment and Prevention of Intraepithelial Neoplasia
J. O'Shaughnessy (2002)
10.1093/JNCI/93.8.605
Randomized phase III intergroup trial of isotretinoin to prevent second primary tumors in stage I non-small-cell lung cancer.
S. Lippman (2001)
10.1200/JCO.2004.08.001
Gefitinib in combination with gemcitabine and cisplatin in advanced non-small-cell lung cancer: a phase III trial--INTACT 1.
G. Giaccone (2004)
10.1038/sj.onc.1207697
Gene expression-based, individualized outcome prediction for surgically treated lung cancer patients
S. Tomida (2004)
10.1093/OCCMED/KQH099
Rounded atelectasis in an asbestos exposed worker.
A. Thompson (2004)
10.1016/j.resp.2004.06.015
Contribution of lymphatic drainage through stomata to albumin removal from pleural space
F. Bodega (2004)
10.1016/J.IJROBP.2004.04.058
Cisplatin/etoposide chemotherapy combined with twice daily thoracic radiotherapy for limited small-cell lung cancer: a clinical phase II trial.
Gui-Yuan Chen (2005)
10.1378/CHEST.125.4.1546
Pleural effusions in hematologic malignancies.
M. Alexandrakis (2004)
Prognostic significance of cyclooxygenase - 2 ( COX - 2 ) and expression of cell cycle inhibitors p 21 and p 27 in human pleural malignant mesothelioma ( Vol 59 , pg 428 , 2004 )
A Baldi (2004)
10.1158/1078-0432.CCR-040021
Novel Agents in the Treatment of Lung Cancer
T. Lynch (2004)
10.1164/RCCM.200312-1683OC
Cytotoxic T cell responses against mesothelioma by apoptotic cell-pulsed dendritic cells.
F. Ebstein (2004)
10.1016/J.ATHORACSUR.2003.08.042
Persistent air leak after pulmonary resection: the water-valve "foam" problem.
A. Cesario (2004)
10.1002/PPUL.10440
Thoracic wall lesions in children
K. Wong (2004)
10.1007/BF00666104
Prostacyclin and its analogues: antimetastatic effects and mechanisms of action
M. R. Schneider (2004)
10.1016/J.ATHORACSUR.2003.08.080
Histological determinants of survival in completely resected T1-2N1M0 nonsmall cell cancer of the lung.
O. Khan (2004)
10.1038/sj.bjc.6601851
CYFRA 21-1 is a prognostic determinant in non-small-cell lung cancer: results of a meta-analysis in 2063 patients
J. Pujol (2004)
10.1378/CHEST.126.1.310
Stage IA lung cancer size and survival.
J. Reich (2004)
10.1378/CHEST.126.3.725
Long-term survival after videothoracoscopic lobectomy for stage I lung cancer.
G. Roviaro (2004)
: perspectives for targeted therapies
JM Kurie (2003)
Combination of cytology , FISH for aneuploidy and RT - PCR for human mammaglobin / mammaglobin B expression improves diagnosis of malignant effusions
M Fiegl
10.1016/J.DDMOD.2005.05.020
Genetically engineered mouse models for lung cancer.
I. Kwak (2004)
10.1148/RADIOL.2333031018
Malignant versus benign nodules at CT screening for lung cancer: comparison of thin-section CT findings.
Feng Li (2004)
Indomethacin reduces lung adenoma number in A/J mice.
T. Moody (2001)
N-(4-hydroxyphenyl)retinamide in the chemoprevention of squamous metaplasia and dysplasia of the bronchial epithelium.
J. Kurie (2000)
10.1378/CHEST.126.6.1721
Tumor markers in undiagnosed pleural effusions.
R. Light (2004)
10.1111/j.1445-5994.2004.00636.x
Five years managing metastatic non‐small cell lung cancer: experience at a teaching hospital
S. Wong (2004)
10.1007/s00134-004-2443-x
Treatment of severe subcutaneous emphysema by fenestrated angiocatheter
M. Ozdogan (2004)
10.1016/J.IJROBP.2004.05.031
Internal target volume determined with expansion margins beyond composite gross tumor volume in three-dimensional conformal radiotherapy for lung cancer.
H. Shih (2004)
Stability of adenosine dearninase during transportation
KD Miller (2004)
Depletion of CXCR 2 inhibits tumor growth and angiogenesis in a murine model of lung cancer
MP Keane (2004)
10.1002/AJMG.1476
Tryptophan hydroxylase gene variant and smoking behavior.
C. Lerman (2001)
10.1016/J.IJROBP.2004.02.066
Bronchial stenosis: an underreported complication of high-dose external beam radiotherapy for lung cancer?
K. L. Miller (2005)
10.1016/J.IJROBP.2004.01.054
Targeted therapies for non-small-cell lung cancer: biology, rationale, and preclinical results from a radiation oncology perspective.
D. Raben (2004)
10.1542/PEDS.113.6.1735
The changing face of pleural empyemas in children: epidemiology and management.
K. D. Schultz (2004)
10.1016/J.RMED.2003.07.001
Prognostic significance of hemostatic parameters in patients with lung cancer.
E. Unsal (2004)
10.3109/01902149809087385
Molecular comparison of human and mouse pulmonary adenocarcinomas.
A. Malkinson (1998)
10.1136/thx.2003.005488
The squirting bleb: image and treatment of inspiration-linked leakage of a peritoneopleural fistula
F. H. Krouwels (2004)
10.1378/CHEST.125.6.2366
Diagnosing pleural tuberculosis.
A. Trajman (2004)
10.1016/J.ANNEMERGMED.2004.02.046
Ultrasonographic diagnosis of pleural effusion in congestive heart failure.
R. Chin (2004)
10.1378/CHEST.126.5.1672
Why do physicians who treat lung cancer get sued?
T. Mclean (2004)
10.1016/J.LUNGCAN.2004.06.007
Final results of the Lung Screening Study, a randomized feasibility study of spiral CT versus chest X-ray screening for lung cancer.
J. Gohagan (2005)
10.1007/s00134-004-2187-7
Incidence, risk factors and outcome of barotrauma in mechanically ventilated patients
A. Anzueto (2004)
10.1016/J.ATHORACSUR.2003.08.012
Pleural perfusion thermo-chemotherapy under VATS: a new less invasive modality for advanced lung cancer with pleural spread.
N. Shigemura (2004)
Screening for lung cancer - Reply
BE Chapman (2004)
Cyr 61 suppresses the growth of non - small - cell lung cancer cells via the beta - catenin - c - myc - p 53 pathway
P Vineis (2004)
Pulmonary nodules-diagnosis and management
10.1002/cncr.20777
The correlation between fatigue, physical function, the systemic inflammatory response, and psychological distress in patients with advanced lung cancer
D. Brown (2005)
10.1056/NEJMC063309
CT screening for lung cancer.
M. Gould (2007)
10.1016/J.LUNGCAN.2003.09.024
Small lung tumors with the size of 1cm or less in diameter: clinical, radiological, and histopathological characteristics.
K. Kishi (2004)
10.1016/J.IJROBP.2004.03.028
Influence of calculation model on dose distribution in stereotactic radiotherapy for pulmonary targets.
U. Haedinger (2005)
10.1189/jlb.1003504
Effects of endothelin ETA receptor antagonism on granulocyte and lymphocyte accumulation in LPS‐induced inflammation
A. L. Sampaio (2004)
10.1378/CHEST.125.2.489
Evaluation of pleural disease with 18-fluorodeoxyglucose positron emission tomography imaging.
B. Duysinx (2004)
10.1002/cncr.20578
Use of inferior vena caval filters and survival in patients with malignancy
M. Wallace (2004)
10.1097/00130404-200405000-00001
Cyclooxygenase‐2 and Gastrointestinal Cancer
J. R. Mann (2004)
10.1002/ijc.20523
JTE‐522, a selective COX‐2 inhibitor, interferes with the growth of lung metastases from colorectal cancer in rats due to inhibition of neovascularization: A vascular cast model study
H. Kobayashi (2004)
10.1093/JNCI/92.21.1764
Repair of tobacco carcinogen-induced DNA adducts and lung cancer risk: a molecular epidemiologic study.
Q. Wei (2000)
10.1016/S0003-4975(03)01464-4
Octreotide and low-fat breast milk in postoperative chylothorax.
M. A. Hamdan (2004)
10.1001/ARCHINTE.164.21.2321
The burden of symptoms among community-dwelling older persons with advanced chronic disease.
L. Walke (2004)
10.1016/S0140-6736(78)90030-2
COMMON FAMILIAL COMPONENT IN LUNG CANCER AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE
B. Cohen (1978)
10.1016/S0022-5347(05)01044-X
Short- and long-term outcomes after large pulmonary resection for germ cell tumors after bleomycin-combination chemotherapy.
R. Andrade (2004)
10.1378/CHEST.125.5_SUPPL.148S
New lung cancer drugs from bradykinin antagonists.
J. Stewart (2004)
10.1038/35094017
Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2
Rajnish A. Gupta (2001)
Interstitial lung disease in patients with non - small - cell lung cancer : causes , mechanisms and management - Introduction
P Camus (2004)
10.7326/0003-4819-142-4-200502150-00005
The Effects of a Smoking Cessation Intervention on 14.5-Year Mortality
N. Anthonisen (2005)
10.1016/J.ATHORACSUR.2003.06.011
Resection of primary pleural pedunculate hemangiopericytoma.
M. Takahama (2004)
10.1038/sj.bjc.6602038
Living arrangements and place of death of older people with cancer in England and Wales: a record linkage study
E. Grundy (2004)
10.1136/thx.2003.008912
Prognostic significance of cyclooxygenase-2 (COX-2) and expression of cell cycle inhibitors p21 and p27 in human pleural malignant mesothelioma
A. Baldi (2004)
10.1136/THX.2004.022889
Giant malignant fibrous histiocytoma of the pleura arising from solitary fibrous tumour
A. Bini (2004)
10.1016/S0003-4975(03)01200-1
Prognostic significance of lymph node metastasis found during pulmonary metastasectomy for extrapulmonary carcinoma.
S. Ercan (2004)
10.1136/THX.2003.007385
Music: a new cause of primary spontaneous pneumothorax
M. Noppen (2004)
10.1200/JCO.2004.12.903
Combining the anti-EGFR agent gefitinib with chemotherapy in non-small-cell lung cancer: how do we go from INTACT to impact?
J. Baselga (2004)
10.1016/J.IJROBP.2003.11.042
Potential role for epidermal growth factor receptor inhibitors in combined-modality therapy for non-small-cell lung cancer.
D. Kim (2004)
10.1038/sj.bjc.6602061
The epidemiology of interstitial lung disease and its association with lung cancer
G. Raghu (2004)
Quantification of 18F-FDG uptake in non-small cell lung cancer: a feasible prognostic marker?
A. Buck (2004)
Effects of 1,4-phenylenebis(methylene)selenocyanate, phenethyl isothiocyanate, indole-3-carbinol, and d-limonene individually and in combination on the tumorigenicity of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in A/J mouse lung.
K. Elbayoumy (1996)
10.17925/OHR.2006.00.02.24
Novel agents in the treatment of lung cancer: conference summary statement.
T. Lynch (2004)
10.1097/01.LAB.0000141898.96929.B3
Talc Pleurodesis: Easy Alternative Solution
Amir M. Khoja (2004)
A 22 - year - old woman with pleural effusion - Pleuropulmonary Amebiasis
A Uslu (2004)
In vitro proton magnetic resonance spectroscopic lactate and choline measurements, 18F-FDG uptake, and prognosis in patients with lung adenocarcinoma.
J. Guo (2004)
10.1080/01902140490495002
Mouse Lung Neuroendocrine Carcinomas: Distinct Morphologies, Same Transcription Factors
R. Ilona Linnoila (2005)
10.1378/CHEST.125.5_SUPPL.89S
Lung cancer risk in relatives of early-onset lung cancer cases.
M. Cote (2004)
10.1165/RCMB.2003-0340OC
Stromal-derived factor-1alpha/CXCL12-CXCR 4 axis is involved in the dissemination of NSCLC cells into pleural space.
Ken-ichi Oonakahara (2004)
10.1016/J.RMED.2004.04.008
Inflammatory parameters after pleurodesis in recurrent malignant pleural effusions and their predictive value.
V. Ukale (2004)
10.1378/CHEST.126.5.1636
Intrapleural injection of transforming growth factor-beta antibody inhibits pleural fibrosis in empyema.
Craig R Kunz (2004)
10.1016/S0003-4975(03)01423-1
Management of newborn lymphangiectasia and chylothorax after cardiac surgery with octreotide infusion.
J. Tibballs (2004)
10.1002/ijc.20226
Reduction of tumor progression and paraneoplastic syndrome development in murine lung adenocarcinoma by nonsteroidal antiinflammatory drugs
Guillermo D Peluffo (2004)
10.1016/J.ATHORACSUR.2003.10.075
Is surgery for T4 non small cell lung cancer worthwhile?: Reply
T. Osaki (2004)
Diagnosis and management of lung cancer: ACCP evidence-based guidelines. Health and Science Policy Committee
C E Reed (2003)
10.1148/RADIOL.2342040026
Lung cancer screening: simulations of effects of imperfect detection on temporal dynamics.
B. Chapman (2005)
10.1038/sj.bjc.6601789
Comparison of an inflammation-based prognostic score (GPS) with performance status (ECOG) in patients receiving platinum-based chemotherapy for inoperable non-small-cell lung cancer
L. M. Forrest (2004)
10.1007/S00420-004-0520-7
Asbestos exposure and radiological abnormalities among maintenance and custodian workers in buildings with friable asbestos-containing materials
M. Matrat (2004)
10.1038/sj.bjc.6602013
The relationship between aberrant methylation and survival in non-small-cell lung cancers
S. Toyooka (2004)
10.1002/SIM.4780080407
Surrogate endpoints in clinical trials: definition and operational criteria.
R. Prentice (1989)
10.1055/S-2004-815800
Bilateral video-assisted thoracoscopic surgery in the supine position for primary spontaneous pneumothorax.
S. Watanabe (2004)
10.1146/annurev.physiol.66.032102.134301
Genetically engineered mouse models for lung cancer.
I. Kwak (2004)
10.1002/cncr.20590
Pulmonary adenocarcinoma is associated with poor long‐term survival after surgical resection
S. Ghosh (2004)
Prostaglandin E synthase: another enzyme in the cyclooxygenase pathway driving epithelial cancer?
J. Kurie (2001)
10.1080/01635588109513704
13-cis retinoic acid and murine pulmonary adenomas: a preliminary report.
J. M. Frasca (1981)
10.1002/ijc.20652
In vivo efficacy of STI571 in xenografted human small cell lung cancer alone or combined with chemotherapy
D. Decaudin (2005)
10.1002/PPUL.10447
Symptomatic spontaneous pneumothorax in term newborn infants
K. A. Al Tawil (2004)
10.1055/S-2004-820869
Minimally invasive thoracic surgery for diagnostic assessment and palliative treatment in recurrent neoplastic pleural effusion.
P. P. Brega-Massone (2004)
10.1016/J.IJROBP.2004.02.037
Epidermal growth factor receptor-targeted therapy with ZD1839: symptom improvement in non-small-cell lung cancer.
R. Natale (2004)
Inhaled isotretinoin (13-cis retinoic acid) is an effective lung cancer chemopreventive agent in A/J mice at low doses: a pilot study.
A. Dahl (2000)
10.1080/08958370490464652
Quantitative Analysis of Asbestos Burden in a Series of Individuals with Lung Cancer and a History of Exposure to Asbestos
R. Dodson (2004)
10.1378/CHEST.126.6.1757
Use of a panel of tumor markers (carcinoembryonic antigen, cancer antigen 125, carbohydrate antigen 15-3, and cytokeratin 19 fragments) in pleural fluid for the differential diagnosis of benign and malignant effusions.
J. M. Porcel (2004)
10.3322/canjclin.53.6.325
Management of Lung Cancer in Older Adults
A. Hurria (2003)
10.1016/J.ATHORACSUR.2004.04.029
Proteasome inhibition sensitizes non-small-cell lung cancer to gemcitabine-induced apoptosis.
Chadrick E. Denlinger (2004)
10.1038/sj.onc.1207897
Individual susceptibility to carcinogens
P. Vineis (2004)
10.1038/sj.bjc.6601781
Do patients with weight loss have a worse outcome when undergoing chemotherapy for lung cancers?
P. Ross (2004)
10.1378/chest.125.6.2345
Severe Acute Respiratory Syndrome Complicated by Spontaneous Pneumothorax
A. Sihoe (2004)
10.1016/J.RCL.2004.09.001
Fluorodeoxyglucose-PET in characterizing solitary pulmonary nodules, assessing pleural diseases, and the initial staging, restaging, therapy planning, and monitoring response of lung cancer.
A. Mavi (2005)
10.1378/CHEST.125.5_SUPPL.144S
Chemoprevention of lung cancer in transgenic mice.
R. Lubet (2004)
10.7326/0003-4819-140-9-200405040-00014
Lung Cancer Screening: Recommendation Statement
U. P. S. T. Force (2004)
10.1378/CHEST.126.3.733
Surgical resection for lung cancer in the octogenarian.
J. Port (2004)
An oncogenic KRAS 2 expression signature identified by cross - species gene - expression analysis
R Meuwissen (2005)
10.1016/J.ATHORACSUR.2003.07.040
Sleeve lobectomy versus pneumonectomy for lung cancer: a comparative analysis of survival and sites or recurrences.
J. Deslauriers (2004)
10.1016/J.ATHORACSUR.2004.04.061
Arterial invasion predicts early mortality in stage I non-small cell lung cancer.
T. Pechet (2004)
10.32388/i4859k
Alveolar adenoma.
E. Saito (2006)
10.1165/RCMB.2003-0409OC
Ultrastructural and chromosomal studies on manganese superoxide dismutase in malignant mesothelioma.
V. Kinnula (2004)
10.1183/09031936.03.00001303
Diagnostic implications of telomerase activity in pleural effusions
G. Dikmen (2003)
10.1200/JCO.20.1.247
Preoperative chemotherapy followed by surgery compared with primary surgery in resectable stage I (except T1N0), II, and IIIa non-small-cell lung cancer.
A. Depierre (2002)
10.1016/J.ATHORACSUR.2004.04.010
Use of quantitative lung scintigraphy to predict postoperative pulmonary function in lung cancer patients undergoing lobectomy.
T. Win (2004)
10.1002/cncr.20843
A pilot clinical trial of vaccination with dendritic cells pulsed with autologous tumor cells derived from malignant pleural effusion in patients with late‐stage lung carcinoma
G. Chang (2005)
10.1016/J.JTCVS.2003.08.034
Immuno-gene therapy with interferon-beta before surgical debulking delays recurrence and improves survival in a murine model of malignant mesothelioma.
Robert J Kruklitis (2004)
10.1023/A:1026300619747
Pleural mesothelioma incidence in Europe: evidence of some deceleration in the increasing trends
F. Montanaro (2004)
10.1093/JNCI/92.12.959
Chemoprevention of lung cancer is proving difficult and frustrating, requiring new approaches.
G. Omenn (2000)
10.1152/JAPPLPHYSIOL.00032.2004
Role of rib cage elastance in the coupling between the abdominal muscles and the lung.
M. Cappello (2004)
10.1378/CHEST.126.2.617
Decreasing prevalence of pleural calcifications among Metsovites with nonoccupational asbestos exposure.
C. Manda-Stachouli (2004)
10.1378/CHEST.126.1.122
Real-time endobronchial ultrasound-guided transbronchial needle aspiration of mediastinal and hilar lymph nodes.
K. Yasufuku (2004)
10.1097/01.TP.0000137324.87116.41
E-Selectin Early Overexpression Induced by Allogeneic Activation in Isolated Mouse Lung
Franck Joucher (2004)
10.1038/sj.bjc.6602064
Diagnosis and management of drug-associated interstitial lung disease
N. Müller (2004)
10.1016/J.ATHORACSUR.2004.06.102
Repeat FDG-PET after neoadjuvant therapy is a predictor of pathologic response in patients with non-small cell lung cancer.
R. Cerfolio (2004)
10.1016/J.ATHORACSUR.2003.08.088
Foscan-mediated photodynamic therapy and operation for malignant pleural mesothelioma.
H. Schouwink (2004)
10.1080/01902140490276393
PROGELATINASE B/MATRIX METALLOPROTEINASE-9 PROENZYME AS A MARKER OF PLEURAL INFLAMMATION
J. Kotyza (2004)
Bronchoscopy biopsy of peripheral lung lesions under electromagnetic guidance - A pilot study
SA Belinsky (2005)
10.1016/S0140-6736(74)92049-2
PROLACTIN AND MIGRAINE
M. T. Epstein (1974)
10.1378/CHEST.125.5_SUPPL.86S
Genetic predisposition to lung cancer.
A. Schwartz (2004)
10.1016/J.RMED.2004.03.020
Chemo-radiotherapy for stage III unresectable non-small cell lung cancer long-term results of a prospective study.
S. Leong (2004)
10.1038/sj.bjc.6601707
α-Tocopheryl succinate and TRAIL selectively synergise in induction of apoptosis in human malignant mesothelioma cells
M. Tomasetti (2004)
10.1378/CHEST.126.6.1764
Pleural manometry: technique and clinical implications.
P. Doelken (2004)
10.1016/J.IJROBP.2004.07.681
Correlation of lung tumor motion with external surrogate indicators of respiration.
J. Hoisak (2004)
10.1378/CHEST.127.1.224
Usefulness of ultrasonography in predicting pleural effusions > 500 mL in patients receiving mechanical ventilation.
A. Roch (2005)
10.1080/09629350400003035
Differential activation of NF kappa B/RelA-p50 and NF kappa B/p50-p50 in control and alcohol-drinking rats subjected to carrageenin-induced pleurisy.
Ashutosh Kumar Singh (2004)
10.1016/J.IJROBP.2004.02.060
Stereotactic radiotherapy for primary lung cancer and pulmonary metastases: a noninvasive treatment approach in medically inoperable patients.
J. Wulf (2004)
10.1097/01.AOG.0000162922.49505.7a
The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial
(2005)
10.1378/CHEST.126.4.1198
Hypofractionated proton beam radiotherapy for stage I lung cancer.
D. Bush (2004)
10.1159/000077428
Carcinoma Arising in the Pleural Cavity following Pneumonectomy for Hydatid Disease
J. Zapatero Gaviria (2004)
10.1378/CHEST.125.5_SUPPL.79S
Lung Cancer Over 17 Years of Aspen Lung Conferences
Y. Miller (2004)
10.1200/JCO.2003.12.139
Depression and psychological distress in patients during the year after curative resection of non-small-cell lung cancer.
Y. Uchitomi (2003)
10.1023/B:QURE.0000015295.74812.06
Quality of life of lung cancer patients: Validation of the Taiwan Chinese version of the EORTC QLQ-C30 and QLQ-LC13
W. Chie (2004)
10.1038/sj.bjc.6601942
Sensitive detection of tumour cells in effusions by combining cytology and fluorescence in situ hybridisation (FISH)
M. Fiegl (2004)
10.1038/sj.bjc.6601810
Prevalence and management of pain in Italian patients with advanced non-small-cell lung cancer
M. Di Maio (2004)
The effect of tumor size on curability of non - small cell lung cancers
JP Wisnivesky
Neoplasms of the lung Carcinoid: diagnosis and management 359
10.1056/NEJMOA030660
The influence of finasteride on the development of prostate cancer.
I. Thompson (2003)
10.1378/CHEST.57.1.65
The management of spontaneous pneumothorax.
M. Seremetis (1970)
10.1016/J.ATHORACSUR.2003.06.023
Pulmonary metastasectomy for uterine cervical cancer: a multivariate analysis.
Kaichiro Yamamoto (2004)
Genetic polymorphism of CYP genes, alone or in combination, as a risk modifier of tobacco-related cancers.
H. Bartsch (2000)
10.1016/J.IJROBP.2004.07.691
A challenge to traditional radiation oncology.
J. Fowler (2004)
10.1136/thorax.2003.009290
BTS randomised feasibility study of active symptom control with or without chemotherapy in malignant pleural mesothelioma: ISRCTN 54469112
M. Muers (2004)
10.1152/JAPPLPHYSIOL.00628.2003
Gas exchange during separate diaphragm and intercostal muscle breathing.
A. Dimarco (2004)
Cost-effectiveness of early intervention: Comparison between intraluminal bronchoscopic treatment and surgical resection for T1N0 lung cancer patients
A Pasic (2004)
BTS guidelines for investigation of unilateral pleural effusion in adults.
A. Tarn (2004)
10.1136/thx.2003.018291
COPD increases the risk of squamous histological subtype in smokers who develop non-small cell lung carcinoma
A. Papi (2004)
Increased epidermal growth factor receptor expression in metaplastic bronchial epithelium.
J. Kurie (1996)
Cytopathological analysis of sputum in patients with airflow obstruction and significant smoking histories.
T. Kennedy (1996)
10.1016/J.RCL.2003.12.005
Emergency ultrasound in trauma patients.
J. McGahan (2004)
10.1055/S-2004-817813
Surgical outcome of combined pulmonary and atrial resection for lung cancer.
A. Bobbio (2004)
10.1378/CHEST.125.3.1103
Asbestos and the pleura: a review.
D. Cugell (2004)
10.1086/422257
A randomized, double-blind, placebo-controlled trial of the use of prednisolone as an adjunct to treatment in HIV-1-associated pleural tuberculosis.
A. Elliott (2004)
10.1002/(SICI)1097-0142(19960901)78:5<1004::AID-CNCR10>3.0.CO;2-6
Lung carcinoma in former smokers
L. Tong (1996)
10.1037/0278-6133.18.1.14
Evidence suggesting the role of specific genetic factors in cigarette smoking.
C. Lerman (1999)
10.1080/08958370490490400
Chemoprevention of Tobacco Smoke-Induced Lung Tumors by Inhalation of an Epigallocatechin Gallate (EGCG) Aerosol: A Pilot Study
H. Witschi (2004)
10.1200/JCO.2004.07.215
Gefitinib in combination with paclitaxel and carboplatin in advanced non-small-cell lung cancer: a phase III trial--INTACT 2.
R. Herbst (2004)
10.1002/ijc.20683
Molecular margin analysis predicts local recurrence after sublobar resection of lung cancer
Brett G Masasyesva (2005)
10.1378/CHEST.125.5_SUPPL.158S
Screening for lung cancer: current status and future directions: Thomas A. Neff lecture.
J. Jett (2004)
Pilate I: Tuberculous pleural effusion
(2004)
Lung metastases: diagnosis and management
10.1200/JCO.1993.11.7.1216
Adjuvant treatment of stage I lung cancer with high-dose vitamin A.
U. Pastorino (1993)
10.1016/S0003-4975(03)01398-5
Sleeve resection of a transcarinal bronchial carcinoid after laser debulking.
M. Mulloy (2004)
10.3322/canjclin.54.1.8
Cancer Statistics, 2004
A. Jemal (2004)
10.1093/JNCI/95.6.470
Variations in lung cancer risk among smokers.
P. Bach (2003)
10.1023/B:CACO.0000036165.13089.e8
Estimating Regional Variation in Cancer Survival: A Tool for Improving Cancer Care
X. Yu (2004)
10.1038/sj.bjc.6602011
Gemcitabine with either paclitaxel or vinorelbine vs paclitaxel or gemcitabine alone for elderly or unfit advanced non-small-cell lung cancer patients
P. Comella (2004)
10.1016/J.ATHORACSUR.2003.07.028
Video-assisted thoracoscopic wedge resection for pulmonary sequestration.
T. Sakuma (2004)
10.1016/J.ATHORACSUR.2004.01.034
The effect of extent of local resection on patterns of disease progression in malignant pleural mesothelioma.
D. Stewart (2004)
Non - small cell lung cancer : Evaluation of pleural abnormalities on CT scans with T - 18 FDG PET
GJ Schaffler (2004)
10.1183/09031936.04.00004504
Assessment of 18F-fluorodeoxyglucose dual-head gamma camera in asbestos lung diseases
B. Melloni (2004)
Human lung cancer chemoprevention strategies
AG Schwartz
Neoplasms of the lung Management of lung cancer 355
10.1378/CHEST.125.3.1144
Video-assisted thoracoscopic surgery is a promising treatment for solitary fibrous tumor of the pleura.
M. Takahama (2004)
10.1378/CHEST.125.6.2268
Talc and silver nitrate induce systemic inflammatory effects during the acute phase of experimental pleurodesis in rabbits.
E. Marchi (2004)
10.1016/J.ATHORACSUR.2004.03.021
Effect of inhibition of multiple steps of angiogenesis in syngeneic murine pleural mesothelioma.
R. Merritt (2004)
10.1038/sj.onc.1208108
Cell type-specific effects of asbestos on intracellular ROS levels, DNA oxidation and G1 cell cycle checkpoint
P. Kopnin (2004)
10.1038/sj.bjc.6601531
Low expression of polypeptide GalNAc N-acetylgalactosaminyl transferase-3 in lung adenocarcinoma: impact on poor prognosis and early recurrence
C. Gu (2004)
10.1378/CHEST.126.5.1529
Intrapleural staphylococcal superantigen induces resolution of malignant pleural effusions and a survival benefit in non-small cell lung cancer.
Shaohua Ren (2004)
p53 N-terminal Ser-15 similar to P and Ser-20 similar to P levels in squamous cell lung cancer after radio/chemotherapy
R M Mroz (2004)
10.1378/CHEST.126.4.1318
Malignant pleural mesothelioma: update, current management, and newer therapeutic strategies.
M. Pistolesi (2004)
10.1007/s00134-004-2186-8
Barotrauma during mechanical ventilation: why aren’t we seeing any more?
J. Ricard (2004)
10.1016/J.RMED.2004.04.006
Simple aspiration versus chest-tube insertion in the management of primary spontaneous pneumothorax: a systematic review.
A. Devanand (2004)
10.1002/ijc.20252
Expression of the tyrosine kinase c‐kit is an independent prognostic factor in patients with small cell lung cancer
U. Rohr (2004)
10.1016/0169-5002(95)96261-s
Declining FEV1 and chronic productive cough in cigarette smokers: a 25-year prospective study of lung cancer incidence in Tecumseh, Michigan.
S. S. Islam (1994)
10.1378/CHEST.126.1.281
Video-assisted thoracoscopic surgery using single-lumen endotracheal tube anesthesia.
R. Cerfolio (2004)
10.1016/j.resp.2004.05.006
Friction and lubrication of pleural tissues
E. D'angelo (2004)
10.1016/J.ATHORACSUR.2004.01.023
Twelve-year experience with left atrial resection in the treatment of non-small cell lung cancer.
G. B. Ratto (2004)
Prevention of chemical carcinogenesis by vitamin A and its synthetic analogs (retinoids).
M. Sporn (1976)
Treatment and prevention of intraepithelial neoplasia: an important target for accelerated new agent development.
J. O'Shaughnessy (2002)
10.1001/JAMA.292.24.2977
Familial risk of lung carcinoma in the Icelandic population.
S. Jónsson (2004)
10.1007/S00420-003-0498-6
Factors influencing long-term survival in mesothelioma patients—results of the German mesothelioma register
V. Neumann (2004)
10.1016/J.AMJMED.2004.01.003
Diagnostic utility of B-type natriuretic peptide in patients with acute dyspnea or pleural effusions.
Rachel L. Zemans (2004)
10.1016/J.RMED.2003.12.017
The prognostic significance of vascular endothelial growth factor levels in sera of non-small cell lung cancer patients.
A. Kaya (2004)
10.1148/RADIOL.2313030347
Thoracic tumors treated with CT-guided radiofrequency ablation: initial experience.
K. Yasui (2004)
10.1378/CHEST.123.1_SUPPL.176S
Treatment of early stage non-small cell lung cancer.
P. Mathur (2003)
10.1016/J.IJROBP.2004.05.054
Evaluation of internal lung motion for respiratory-gated radiotherapy using MRI: Part II-margin reduction of internal target volume.
H. Liu (2004)
10.1378/CHEST.126.6.1985
Differences of opinion: a survey of knowledge and bias among clinicians regarding the role of chemotherapy in metastatic non-small cell lung cancer.
R. Jennens (2004)
Long-term changes in pulmonary function tests after definitive irradiation for lung cancer -Response
K L Miller (2004)
10.1038/ng1490
An oncogenic KRAS2 expression signature identified by cross-species gene-expression analysis
A. Sweet-Cordero (2005)
Randomized trial of supplemental beta-carotene to prevent second head and neck cancer.
S. Mayne (2001)
10.1038/bjc.1992.156
The effect of the synthetic retinoid etretinate on sputum cytology: results from a randomised trial.
A. Arnold (1992)
10.1093/JNCI/82.15.1272
Evidence for mendelian inheritance in the pathogenesis of lung cancer.
T. A. Sellers (1990)
10.1053/SRAO.2000.9674
Non-small cell lung cancer. Introduction.
J. Bonner (2000)
10.1378/CHEST.125.4.1581
The use of cardiopulmonary bypass during resection of locally advanced thoracic malignancies: a 10-year two-center experience.
J. Byrne (2004)
10.1159/000076679
Thrombocytosis as a Useful Prognostic Indicator in Patients with Lung Cancer
K. Aoe (2004)
Tumour necrosis factor - a in pleural fluid
G Simpson (2004)
Screening for lung cancer with low - dose spiral computer tomography
H Arimura
Ifosfamide , Mesna , and Interferon - Alpha 2 A combination chemoimmunotherapy in malignant mesothelioma - Results of a single center in central Anatolia
O Er (2004)
Inhibition of DNA methylation and histone deacetylation prevents murine lung cancer.
S. Belinsky (2003)
10.1016/0304-3835(84)90051-X
Effect of vitamin A on lung tumorigenesis in irradiated and unirradiated strain A mice.
T. A. Mian (1984)
The tobacco smoke model is a difficult one in which to demonstrate chemoprevention, but has obvious clinical relevance
The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group
(1994)
10.1016/J.ATHORACSUR.2003.11.038
Axillary thoracotomy versus videothoracoscopy for the treatment of primary spontaneous pneumothorax.
J. Freixinet (2004)
10.1126/SCIENCE.1101637
Gefitinib-Sensitizing EGFR Mutations in Lung Cancer Activate Anti-Apoptotic Pathways
R. Sordella (2004)
10.1136/thx.2004.038406
Some consensus but little evidence: guidelines on management of pleural infection in children
I. Balfour-Lynn (2005)
10.1183/09031936.04.00079304
Characterisation of pleural inflammation occurring after primary spontaneous pneumothorax
A. De Smedt (2004)
10.1002/cncr.20770
Fatigue is becoming an exhausting problem
J. Ruckdeschel (2005)
10.1016/J.ATHORACSUR.2003.11.021
Gender differences in non-small-cell lung cancer survival: an analysis of 4,618 patients diagnosed between 1997 and 2002.
A. Visbal (2004)
10.1183/09031936.04.00137403
Efficacious pleurodesis with OK‐432 and doxorubicin against malignant pleural effusions
K. Kishi (2004)
Chemoprevention of benzo(a)pyrene-induced lung tumors in mice by the farnesyltransferase inhibitor R115777.
W. Gunning (2003)
10.1056/NEJM199605023341801
Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease.
C. Hennekens (1996)
10.1002/ijc.20395
Reduced expression of class II histone deacetylase genes is associated with poor prognosis in lung cancer patients
H. Osada (2004)
10.1111/j.1532-5415.2004.52365.x
Outcomes and Characteristics of Patients Discharged Alive from Hospice
J. Kutner (2004)
10.1378/CHEST.125.5_SUPPL.156S-A
A pilot evaluation of micrometastases for the prediction of outcome in lung cancer.
A. Thompson (2004)
10.1023/A:1017196423775
Cancer Causes & Control
E. Buiatti (1998)
10.1378/CHEST.125.5_SUPPL.128S
Chemoprevention of tobacco smoke-induced lung cancer: what animal studies tell us.
H. Witschi (2004)
10.1097/01.CAD.0000127664.66472.60
Antitumor activity of erlotinib (OSI-774, Tarceva) alone or in combination in human non-small cell lung cancer tumor xenograft models
B. Higgins (2004)
10.1378/CHEST.126.6.1750
The impact of smoking status on the behavior and survival outcome of patients with advanced non-small cell lung cancer: a retrospective analysis.
C. Toh (2004)
10.1002/cncr.21209
Repeat needle biopsies combined with clinical observation are safe and accurate in the management of a solitary pulmonary nodule
D. Sortini (2005)
Management of spontaneous pneumothorax - Reply
S Watanabe (2004)
10.1378/CHEST.125.5_SUPPL.152S-A
Phospho-Akt overexpression in non-small cell lung cancer confers significant stage-independent survival disadvantage.
O. David (2004)
10.1378/CHEST.125.2.744
Changing patterns in asbestos-induced lung disease.
J. Ohar (2004)
10.1016/J.ATHORACSUR.2003.04.005
Extrapleural thoracoscopic excision of a mediastinal bronchogenic cyst in a patient with dense pleural adhesions.
Hiroki Sato (2004)
10.1159/000076681
Vascular Stenting for Palliation of Superior Vena cava Obstruction in Non-Small-Cell Lung Cancer Patients: A Future ‘Standard’ Procedure?
L. Greillier (2004)
10.1002/ijc.20062
A vitamin E analogue suppresses malignant mesothelioma in a preclinical model: A future drug against a fatal neoplastic disease?
M. Tomasetti (2004)
10.1378/CHEST.125.3.1028
Pneumothorax in pulmonary Langerhans cell histiocytosis.
J. L. Mendez (2004)
10.1002/cncr.20406
Risk assessment of patients with hematologic malignancies who develop fever accompanied by pulmonary infiltrates
M. Offidani (2004)
10.1016/J.IJROBP.2004.01.033
P53-independent thermosensitization by mitomycin C in human non-small-cell lung cancer cells.
Zhao-Hui Jin (2004)
10.1016/J.ATHORACSUR.2003.08.081
Is surgery for T4 non-small-cell lung cancer worthwhile?
C. Pramesh (2004)
10.1378/CHEST.125.2.566
Treatment of complicated parapneumonic pleural effusion with intrapleural streptokinase in children.
Chih-Ta Yao (2004)
10.1158/0008-5472.CAN-03-3273
A Chemically Induced Model for Squamous Cell Carcinoma of the Lung in Mice
Y. Wang (2004)
10.1093/JNCI/30.2.289
Familial aggregation of lung cancer in humans.
G. Tokuhata (1963)
10.1016/J.ATHORACSUR.2004.05.056
SCCRO expression correlates with invasive progression in bronchioloalveolar carcinoma.
I. Sarkaria (2004)
10.1146/ANNUREV.PUBLHEALTH.19.1.73
Chemoprevention of lung cancer: the rise and demise of beta-carotene.
G. Omenn (1998)
10.1016/J.IJROBP.2004.09.052
Predictors of radiation pneumonitis after radiotherapy in lung cancer.
B. Jeremic (2005)
ultrasound study
M Fiegl (2004)
10.1056/NEJM199009203231205
Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck.
W. Hong (1990)
10.1111/J.1527-5299.2004.03271.X
BNP Consensus Panel 2004: A clinical approach for the diagnostic, prognostic, screening, treatment monitoring, and therapeutic roles of natriuretic peptides in cardiovascular diseases.
M. Silver (2004)
10.1016/s0003-4975(03)01385-7
Limited resection of non-small cell lung cancer: should brachytherapy be indicated in all cases?: Reply
B. Daly (2004)
10.1002/cncr.20542
Expression of syndecan‐1 and expression of epidermal growth factor receptor are associated with survival in patients with nonsmall cell lung carcinoma
L. Shah (2004)
10.1016/J.RMED.2003.10.011
Differential diagnosis of pleural effusions by fuzzy-logic-based analysis of cytokines.
Pawel Chomej (2004)
10.1055/S-2004-821075
Outcome of surgery for small cell lung cancer -- response to induction chemotherapy predicts survival.
H. Nakamura (2004)
10.1002/cncr.20547
Lung carcinoma symptoms—An independent predictor of survival and an important mediator of African‐American disparity in survival
C. M. Tammemagi (2004)
10.1016/0169-5002(94)92175-X
Randomized placebo-controlled trial of isotretinoin in chemoprevention of bronchial squamous metaplasia.
J. S. Lee (1994)
10.1093/JNCI/92.12.977
EUROSCAN, a randomized trial of vitamin A and N-acetylcysteine in patients with head and neck cancer or lung cancer. For the EUropean Organization for Research and Treatment of Cancer Head and Neck and Lung Cancer Cooperative Groups.
N. van Zandwijk (2000)
10.1016/J.LUNGCAN.2003.09.014
Pleurodesis in recurrent pleural effusions: a randomized comparison of a classical and a currently popular drug.
V. Ukale (2004)
10.1002/ijc.20516
RLIP76 (RALBP1)‐mediated transport of leukotriene C4 (LTC4) in cancer cells: Implications in drug resistance
R. Sharma (2004)
10.1016/J.ATHORACSUR.2003.08.041
Sealing of the mediastinum with a local hemostyptic agent reduces chest tube duration after complete mediastinal lymph node dissection for stage I and II non-small cell lung carcinoma.
M. Czerny (2004)
10.1002/ijc.20574
Antitumor activity of the intratumoral injection of fowlpox vectors expressing a triad of costimulatory molecules and granulocyte/macrophage colony stimulating factor in mesothelioma
P. Triozzi (2005)
10.1016/J.IJROBP.2004.04.013
Improved local control with higher doses of radiation in large-volume stage III non-small-cell lung cancer.
R. Rengan (2004)
10.1159/000081750
Primum non nocere and Malignant Pleural Effusions
Veena B. Antony (2004)
10.1016/J.ATHORACSUR.2003.08.049
Effect of prior malignancy on survival after cardiac surgery.
W. Mistiaen (2004)
10.1016/J.IJROBP.2004.04.037
Regional differences in lung radiosensitivity after radiotherapy for non-small-cell lung cancer.
Y. Seppenwoolde (2004)
10.1378/CHEST.126.3.666
Complications of CT scan-guided lung biopsy: lesion size and depth matter.
A. Gohari (2004)
10.1055/S-2004-817808
Mediastinal solitary fibrous tumor: report of a case with direct invasion to the trachea.
T. Shiraishi (2004)
10.1038/sj.bjc.6601887
High levels of untreated distress and fatigue in cancer patients
L. Carlson (2004)
10.1200/JCO.2004.08.158
Bronchioloalveolar pathologic subtype and smoking history predict sensitivity to gefitinib in advanced non-small-cell lung cancer.
V. Miller (2004)
Percutaneous radiofrequency ablation of pulmonary malignancies: Giving credit for previous work -Response
J M Lee (2004)
10.1093/JNCI/DJI289
Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment.
B. Edwards (2005)
10.1378/CHEST.126.3.748
Risk factors of pneumothorax and bleeding: multivariate analysis of 660 CT-guided coaxial cutting needle lung biopsies.
K. Yeow (2004)
Estimation of size of pneumothorax under the new BTS guidelines.
S. S. Chan (2004)
10.1200/jco.2004.22.14_suppl.7077
Phase I trial of gefitinib (ZD1839) in combination with concurrent carboplatin, paclitaxel and radiation therapy in patients with stage III non-small cell lung cancer.
D. Rischin (2004)
10.1183/09031936.05.00060804
Prognostic role of epidermal growth factor receptor in stage III nonsmall cell lung cancer
T. Berghmans (2005)
10.1378/CHEST.126.5.1522
Talc pleurodesis: basic fibroblast growth factor mediates pleural fibrosis.
V. Antony (2004)
10.1002/cncr.20288
Annual report to the nation on the status of cancer, 1975–2001, with a special feature regarding survival
A. Jemal (2004)
10.1016/J.RMED.2003.09.002
Vascular endothelial growth factor correlates with matrix metalloproteinase-9 in the pleural effusion.
H. Y. Jin (2004)
10.1002/cyto.b.20023
FISH cytogenetics and prognosis in breast and non–small cell lung cancers
A. Massoner (2004)
10.1016/J.ATHORACSUR.2003.10.111
Percutaneous venovenous perfusion-induced systemic hyperthermia for lung cancer: a phase I safety study.
J. Zwischenberger (2004)
10.1016/J.RMED.2003.11.003
Prognostic value of combination of Cyfra 21-1, CEA and NSE in patients with advanced non-small cell lung cancer.
F. Barlesi (2004)
10.1378/CHEST.125.5_SUPPL.150S
Role of parathyroid hormone-related protein in lung cancer cell survival.
R. Hastings (2004)
10.1016/J.ATHORACSUR.2004.05.007
Pleural biopsy: a reliable method for determining the diagnosis but not subtype in mesothelioma.
R. Bueno (2004)
10.1038/sj.bjc.6602258
The role of RAS oncogene in survival of patients with lung cancer: a systematic review of the literature with meta-analysis
C. Mascaux (2005)
This recent review notes that COX-2-specific agents have promise in the chemoprevention of gastrointestinal tumors
10.1111/j.1445-5994.2004.00645.x
Comparison of patterns of care in lung cancer in three area health services in New South Wales, Australia
S. Vinod (2004)
10.1378/CHEST.125.6.2083
Lung density measurements in spontaneous pneumothorax demonstrate airtrapping.
H. Smit (2004)
10.1002/cncr.20421
Postoperative serum carcinoembryonic antigen levels in patients with pathologic stage IA nonsmall cell lung carcinoma
N. Sawabata (2004)
10.1016/J.AMJMED.2004.06.044
Unilateral transudative pleural effusion: an exceptional cause.
E. Antón (2004)
10.1159/000079634
Is There a Place for Intraluminal Bronchoscopic Treatment of T1N0 Lung Cancer?
V. Ninane (2004)
10.1136/thx.45.2.81
Management of malignant pleural effusions.
M. Tattersall (1990)
Alternatve widely available, inexpensive agents for pleurodesis Review
10.1080/01902140490495499
Mouse Models Incorporating Alterations In The Major Tumor Suppressor Genes P53 And P16: Their Use In Screening For Potential Carcinogens, Developing Further Relevant Mouse Models, And Screening For Potential Chemopreventive And Chemotherapetutic Agents
R. Lubet (2005)
10.1258/JRSM.98.1.23
Splenomegaly, anaemia and pleural effusion.
P. Kojodjojo (2005)
Interferon-gamma differentially regulates susceptibility of lung cancer cells to telomerase-specific cytotoxic T lymphocytes.
K. Tajima (2004)
10.1002/cncr.20027
Clinical significance of bone marrow microinvolvement in nonsmall cell lung carcinoma
Chung-Ping Hsu (2004)
10.1378/CHEST.125.5_SUPPL.111S-A
Gene expression patterns, prognostic and diagnostic markers, and lung cancer biology.
N. Kaminski (2004)
10.1164/RCCM.2202043
Pleural fluid transforming growth factor-beta1 correlates with pleural fibrosis in experimental empyema.
S. Sasse (2003)
10.1016/j.ejheart.2003.11.017
NT‐brain natriuretic peptide levels in pleural fluid distinguish between pleural transudates and exudates
J. Tomcsányi (2004)
10.1016/J.ATHORACSUR.2004.03.010
Interleukin-4 receptor cytotoxin as therapy for human malignant pleural mesothelioma xenografts.
B. Beseth (2004)
10.1038/sj.bjc.6601547
Economics of the clinical management of lung cancer in France: an analysis using a Markov model
C. Chouaïd (2004)
10.1023/B:QURE.0000037481.36604.eb
Baseline FACT-G score is a predictor of survival for advanced lung cancer
M. Dharma-Wardene (2004)
10.1093/IJE/28.5.829
GSTM1, smoking and lung cancer: a case-control study.
I. Stücker (1999)
10.1016/J.ACRA.2004.02.009
Computerized scheme for automated detection of lung nodules in low-dose computed tomography images for lung cancer screening.
H. Arimura (2004)
10.1158/0008-5472.CAN-04-1070
Pulmonary Prostacyclin Synthase Overexpression Chemoprevents Tobacco Smoke Lung Carcinogenesis in Mice
R. Keith (2004)
10.1093/CARCIN/20.7.1375
Chemoprevention of tobacco smoke-induced lung tumors in A/J strain mice with dietary myo-inositol and dexamethasone.
H. Witschi (1999)
10.1378/CHEST.125.5.1805
Emphysema and pneumothorax after percutaneous tracheostomy: case reports and an anatomic study.
B. Fikkers (2004)
10.1378/CHEST.126.2.656
Surgery in lung cancer patients.
H. Esteva (2004)
10.1038/sj.onc.1207929
XIAP and survivin as therapeutic targets for radiation sensitization in preclinical models of lung cancer
C. Cao (2004)
10.1016/S1535-6108(03)00220-4
Induction of small cell lung cancer by somatic inactivation of both Trp53 and Rb1 in a conditional mouse model.
R. Meuwissen (2003)
10.1093/TOXSCI/68.2.322
A mouse lung tumor model of tobacco smoke carcinogenesis.
H. Witschi (2002)
10.1002/cncr.20308
Long‐term efficacy and safety of zoledronic acid in the treatment of skeletal metastases in patients with nonsmall cell lung carcinoma and other solid tumors
L. Rosen (2004)
10.1016/J.ATHORACSUR.2004.03.102
Surgical treatments for multiple primary adenocarcinoma of the lung.
M. Nakata (2004)
10.1159/000077432
Pleural Effusion in Yellow Nail Syndrome: Treatment with Bilateral Pleuro-Peritoneal Shunts
N. Moorjani (2004)
10.1378/CHEST.125.5_SUPPL.167S
Experience with surgical intervention for screening-detected lung cancer.
M. Tsuboi (2004)
10.1016/J.ATHORACSUR.2003.08.090
Adenosquamous carcinoma of the lung and visceral pleural invasion.
M. Riquet (2004)
10.1016/J.IJROBP.2004.08.007
Nonrigid registration method to assess reproducibility of breath-holding with ABC in lung cancer.
David Sarrut (2005)
10.1016/J.ATHORACSUR.2004.04.007
Recent results of postoperative mortality for surgical resections in lung cancer.
S. Watanabe (2004)
10.1148/RADIOL.2311030634
CT screening for lung cancer: suspiciousness of nodules according to size on baseline scans.
C. Henschke (2004)
10.1038/sj.onc.1207881
Expression of the secreted frizzled-related protein gene family is downregulated in human mesothelioma
Amie Y Lee (2004)
10.1016/J.ATHORACSUR.2003.07.017
Photodynamic therapy in nonsmall cell lung cancer: a systematic review.
D. Maziak (2004)
10.1016/J.IJROBP.2004.07.707
Correlation of gross tumor volume excursion with potential benefits of respiratory gating.
G. Starkschall (2004)
10.1016/J.RMED.2003.08.014
Determination of the serum matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) in patients with either advanced small-cell lung cancer or non-small-cell lung cancer prior to treatment.
C. Jumper (2004)
10.1038/sj.bjc.6602233
Ki-67 expression and patients survival in lung cancer: systematic review of the literature with meta-analysis
B. Martin (2004)
10.1183/09031936.04.00010504
Metalloproteinases and tissue inhibitors of metalloproteinases in exudative pleural effusions
D. Iglesias (2005)
10.1016/J.ATHORACSUR.2004.05.065
Accuracy of helical CT in the detection of pulmonary metastases: is intraoperative palpation still necessary?
A. M. Parsons (2004)
10.1258/JRSM.97.9.435
Bilateral spontaneous pneumothorax in a cannabis smoker.
Kathryn Goodyear (2004)
10.1016/J.RCL.2004.01.002
Emergent ultrasound interventions.
D. Nakamoto (2004)
10.1159/000080638
Safety and Yield of Ultrasound-Assisted Transthoracic Biopsy Performed by Pulmonologists
A. Diacon (2004)
10.1016/J.ATHORACSUR.2004.02.043
Surgical management of thoracic malignancies invading the heart or great vessels.
B. Park (2004)
10.1086/426139
Ex vivo characterization of early secretory antigenic target 6-specific T cells at sites of active disease in pleural tuberculosis.
K. A. Wilkinson (2005)
Radiation therapy of small cell lung cancer with 177Lu-DOTA-Tyr3-octreotate in an animal model.
A. Schmitt (2004)
10.1016/J.ATHORACSUR.2004.04.066
Combined resection of superior vena cava for lung carcinoma: prognostic significance of patterns of superior vena cava invasion.
K. Suzuki (2004)
The economic impact of false-positive cancer screens.
J. E. Lafata (2004)
10.1378/CHEST.126.4.1195
Soluble receptor-binding cancer antigen expressed on SiSo cells in pleural fluid: a potential diagnostic marker for malignant pleural effusion.
K. Aoe (2004)
10.1378/CHEST.125.5_SUPPL.97S-A
Molecular targets for cancer therapy and prevention.
A. Gazdar (2004)
10.1158/1078-0432.CCR-04-0686
A Randomized Phase IIb Trial of Pulmicort Turbuhaler (Budesonide) in People with Dysplasia of the Bronchial Epithelium
S. Lam (2004)
10.7326/0003-4819-137-1-200207020-00017
Chemoprevention of Breast Cancer: A Summary of the Evidence for the U.S. Preventive Services Task Force
L. Kinsinger (2002)
10.1165/RCMB.2003-0238OC
Proteomic analysis of exosomes isolated from human malignant pleural effusions.
M. P. Bard (2004)
10.1378/CHEST.125.3.1059
Safety of Ultrasound-Guided Thoracentesis in Patients Receiving Mechanical Ventilation
P. Mayo (2004)
10.1016/J.IJROBP.2004.01.055
Long-term results of a phase III trial comparing once-daily radiotherapy with twice-daily radiotherapy in limited-stage small-cell lung cancer.
S. Schild (2004)
10.1183/09031936.04.00096404
Spontaneous pneumomediastinum in patients with severe acute respiratory syndrome
C. Chu (2004)
10.1148/RADIOL.2312030553
Small pulmonary nodules: reproducibility of three-dimensional volumetric measurement and estimation of time to follow-up CT.
W. Kostis (2004)
10.1136/thx.2003.018044
Effect of comorbidity on the treatment and prognosis of elderly patients with non-small cell lung cancer
M. Janssen-Heijnen (2004)
Empyema and pleural infections
10.1200/JCO.2004.11.057
Determinants of tumor response and survival with erlotinib in patients with non--small-cell lung cancer.
R. Pérez-Soler (2004)
10.1086/425999
Simian virus 40 and human disease.
K. Shah (2004)
radiograph - The Lung Screening Study of the National Cancer Institute
JK Gohagan (2004)
10.1148/RADIOL.2323040082
Percutaneous radiofrequency ablation of pulmonary malignancies: giving credit for previous work.
P. Cascade (2004)
10.1002/ijc.20436
Inherited predisposition to early onset lung cancer according to histological type
X. Li (2004)
10.1016/J.RMED.2003.09.006
Overexpression of cyclooxygenase-2 in non-small cell lung cancer.
D. Petkova (2004)
10.1126/SCIENCE.1103333
COX-2-Derived Prostacyclin Confers Atheroprotection on Female Mice
K. Egan (2004)
10.1086/423857
A major lung cancer susceptibility locus maps to chromosome 6q23-25.
J. Bailey-Wilson (2004)
10.1016/J.ATHORACSUR.2004.01.002
Evolution of surgical outcomes for nonsmall cell lung cancer: time trends in 1465 consecutive patients undergoing complete resection.
M. Okada (2004)
10.1111/j.1440-1843.2004.00599.x
Radiology in pleural disease: State of the art
A. L. Evans (2004)
10.1016/S0140-6736(04)17102-X
Evidence against a role for SV40 infection in human mesotheliomas and high risk of false-positive PCR results owing to presence of SV40 sequences in common laboratory plasmids
F. Lopez-Rios (2004)
10.1016/J.ATHORACSUR.2003.06.033
Pneumothorax after left pneumonectomy: implantation of an intrapleural prosthesis.
C. Périgaud (2004)
10.1016/J.ATHORACSUR.2003.07.041
Simultaneous lung resection for cancer and myocardial revascularization without cardiopulmonary bypass (off-pump coronary artery bypass grafting).
W. Dyszkiewicz (2004)
10.1016/J.ATHORACSUR.2003.10.014
Preoperative pulmonary function as a prognostic factor for stage I non-small cell lung carcinoma.
T. Iizasa (2004)
10.1182/BLOOD-2003-08-2717
Cognate recognition of the endothelium induces HY-specific CD8+ T-lymphocyte transendothelial migration (diapedesis) in vivo.
F. Marelli-Berg (2004)
10.1378/CHEST.125.5_SUPPL.154S
New targets for detection and treatment of small cell lung cancer.
N. Pedersen (2004)
10.1016/S0140-6736(03)14188-8
Early lung-cancer detection with spiral CT and positron emission tomography in heavy smokers: 2-year results
U. Pastorino (2003)
10.1200/JCO.2004.10.148
Phase I study of G3139, a bcl-2 antisense oligonucleotide, combined with carboplatin and etoposide in patients with small-cell lung cancer.
C. Rudin (2004)
10.1038/sj.bjc.6602149
Coexpression of epidermal growth factor receptor with related factors is associated with a poor prognosis in non-small-cell lung cancer
D. Swinson (2004)
Outcome analysis undergoing chest of cirrhotic patients tube placement
LU Liu (2004)
Loss of function of p16 gene and prognosis of pulmonary adenocarcinoma
田中 良太 (2005)
10.1016/S0169-5002(03)00137-5
Epidermal growth factor family of receptors in preneoplasia and lung cancer: perspectives for targeted therapies.
F. Hirsch (2003)
10.1002/cncr.20825
Bronchopulmonary carcinoid in multiple endocrine neoplasia type 1
N. Sachithanandan (2005)
10.1200/JCO.2002.03.038
Selective oral epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 is generally well-tolerated and has activity in non-small-cell lung cancer and other solid tumors: results of a phase I trial.
R. Herbst (2002)
10.1378/CHEST.125.3.987
Comparison of six biological markers for the diagnosis of tuberculous pleuritis.
A. Hiraki (2004)
10.1016/S0140-6736(04)17108-0
Pleural mesothelioma: little evidence, still time to do trials
T. Treasure (2004)
10.1183/09031936.04.00069104
Medical thoracoscopy: hormone receptor content in pleural metastases due to breast cancer
C. Schwarz (2004)
10.1378/CHEST.126.6.1733
The relationship between cigarette smoking and quality of life after lung cancer diagnosis.
Y. Garces (2004)
10.1016/J.ATHORACSUR.2004.05.083
Feasibility and results of awake thoracoscopic resection of solitary pulmonary nodules.
E. Pompeo (2004)
chemoprevention : moving from concept to reality
RL Keith (2003)
10.1159/000080642
Urinothorax: Case Report and Review of the Literature with Emphasis on Biochemical Diagnosis
E. García-Pachón (2004)
10.1038/sj.onc.1207951
The search for low-penetrance cancer susceptibility alleles
R. Houlston (2004)



This paper is referenced by
10.1142/9781848163652_0001
1 Cancer and Tobacco: Its Effects on Individuals and Populations
B. Stewart (2009)
10.1186/1478-811X-9-13
Beyond DNA binding - a review of the potential mechanisms mediating quinacrine's therapeutic activities in parasitic infections, inflammation, and cancers
R. Ehsanian (2011)
10.1038/nrclinonc.2013.64
Lung cancer chemoprevention: current status and future prospects
R. Keith (2013)
10.1158/0008-5472.CAN-06-2754
Tumor-suppressive effects of MBP-1 in non-small cell lung cancer cells.
A. Ghosh (2006)
10.1186/1746-1596-8-44
A gene expression profile test to resolve head & neck squamous versus lung squamous cancers
A. Lal (2013)
10.1164/RCCM.200701-087ED
Inhaled corticosteroids and lung cancer chemoprevention.
Y. Miller (2007)
Cancer Nanotechnology Plan 2015
M. Davis (2015)
10.1038/nrc2674
Chemoprevention of lung carcinogenesis in addicted smokers and ex-smokers
S. Hecht (2009)
10.1007/978-1-4614-3197-8_3
Genetic Susceptibility to Lung Cancer
T. Allen (2012)
Cáncer de pulmón en no fumadores
I. Palma (2010)
10.1007/s13187-011-0232-0
Cancer Prevention Interdisciplinary Education Program at Purdue University: Overview and Preliminary Results
Dorothy Teegarden (2011)
10.3724/SP.J.1206.2009.00308
Construction and Characterization of Oncolytic Adenovirus Controlled Under Heat Shock Protein70 Gene Promoter*: Construction and Characterization of Oncolytic Adenovirus Controlled Under Heat Shock Protein70 Gene Promoter*
Fang Wei (2010)
10.1002/ijc.22331
Lung cancer risk prediction: A tool for early detection
A. Cassidy (2007)
10.1097/00006205-200701000-00008
Lung cancer diagnosis in primary care.
Brooke M Simon (2007)
10.3978/j.issn.2072-1439.2013.08.43
The pivotal role of pathology in the management of lung cancer.
Morgan R. Davidson (2013)
10.1200/JCO.2006.06.8015
Lung cancer in never smokers: a review.
J. Subramanian (2007)
10.1007/978-0-387-72114-9_2
Molecular genetics of lung and pleural neoplasms
P. Cagle (2008)
10.1038/ncponc0718
Lung carcinoma in African Americans
O. Abidoye (2007)
10.1016/j.semcancer.2019.09.021
Repurposing Quinacrine for Treatment-Refractory Cancer.
D. Oien (2019)
10.1158/1078-0432.CCR-07-0113
Genetic Variants in Cell Cycle Control Pathway Confer Susceptibility to Lung Cancer
W. Wang (2007)
10.1097/01.cej.0000215612.98132.18
Chemoprevention of lung cancers: lessons from CARET, the beta-carotene and retinol efficacy trial, and prospects for the future
G. Omenn (2007)
10.1158/1055-9965.EPI-06-0923
The Association between the Anti-inflammatory Protein CC10 and Smoking Status among Participants in a Chemoprevention Trial
J. Chen (2007)
10.1007/978-3-319-62941-4
Precision Molecular Pathology of Lung Cancer
P. Cagle (2018)
10.1016/j.canep.2010.08.007
Association studies of excision repair cross-complementation group 1 (ERCC1) haplotypes with lung and head and neck cancer risk in a Caucasian population.
N. R. Jones (2011)
10.1177/1758834013482345
Detection and minimally invasive treatment of early squamous lung cancer
J. M. Daniels (2013)
10.1165/RCMB.2005-0158OE
Pathogenesis of lung cancer: 100 year report.
Y. Miller (2005)
Semantic Scholar Logo Some data provided by SemanticScholar